ICU Medical (ICUI) FY2014 results: revenue $309 million, down 1.4% on the year
ICU Medical Inc. (ICUI) reported revenue of $309 million for fiscal 2014, the year ended 31 December 2014, down 1.4% on the year before. Net income was $26 million, down 34.8%, and diluted earnings per share $1.68. The figures are the company's own, from the 10-K it filed with the SEC on 20 February 2015.
Revenue
$309 million
-1.4% on the year
FY2007FY2014
Operating margin
12.6%
16.6% a year earlier
FY2007FY2014
Net income
$26 million
-34.8% on the year
FY2007FY2014
Diluted EPS
$1.68
-36.6% on the year
FY2007FY2014
this yearthe year beforeHover a bar for its figure.
The year in brief
Income statement (profit and loss)
$ million
FY2014
FY2013
FY2012
On the year
Last 8 years
Revenue
309
314
317
-1.4%
Cost of revenue
158
159
160
-0.7%
Gross profit
151
155
157
-2.2%
Gross margin
49.0%
49.3%
49.4%
Research and development
18.3
12.4
10.6
+47.8%
Selling, general and administrative
88.9
89.0
84.6
-0.1%
Operating income
39.0
51.9
61.3
-24.9%
Operating margin
12.6%
16.6%
19.3%
Pre-tax income
39.8
52.7
61.8
-24.5%
Income tax
13.5
12.3
20.6
+9.4%
Effective tax rate
33.8%
23.3%
33.2%
Net income
26.3
40.4
41.3
-34.8%
Net margin
8.5%
12.9%
13.0%
Diluted EPS
$1.68
$2.65
$2.80
-36.6%
$ million except per share. Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.
Cash flow
$ million
FY2014
FY2013
FY2012
On the year
Last 8 years
Operating cash flow
66.3
65.7
66.3
+0.9%
Capital expenditure
16.6
18.4
19.2
-9.8%
Free cash flow
49.7
47.3
47.1
+5.1%
Free cash flow margin
16.1%
15.1%
14.9%
Cash from investing
-21.8
-13.1
-41.4
Cash from financing
13.6
24.4
21.6
-44.1%
Depreciation and amortisation
19.4
19.5
19.0
-0.3%
Share-based compensation
9.6
5.4
5.6
+76.5%
Buybacks
5.8
3.0
0.0
+92.4%
Diluted shares, weighted
16m
15m
15m
+2.4%
Shares outstanding at period end
16m
15m
14m
+3.3%
Balance sheet
$ million
FY2014
FY2013
FY2012
On the year
Last 8 years
Shareholders' equity
508
465
391
+9.4%
Debt
0.0
0.0
0.0
Other liabilities
32.9
34.9
37.7
-5.9%
Total liabilities and equity
541
500
429
+8.3%
Fixed assets
86.1
87.9
85.9
-2.0%
Goodwill
1.5
1.5
1.5
0.0%
Intangible assets
7.1
8.5
10.0
-16.8%
Investments
71.0
70.9
79.3
+0.1%
Cash and equivalents
276
226
147
+22.0%
Receivables
39.1
45.3
49.1
-13.8%
Inventory
36.9
34.5
36.3
+7.2%
Other assets
23.7
25.2
19.5
-5.7%
Total assets
541
500
429
+8.3%
10-K for the year ended 31 December 2014, filed 20 February 2015: the filing.